Nestford, MA, United States of America

Anu Mahadevan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anu Mahadevan. Retrieved from https://idiyas.com/inventor/anu-mahadevan-vmwo25p3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anu Mahadevan: Innovator in Pharmaceutical Chemistry

Introduction

Anu Mahadevan is a notable inventor based in Nestford, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Anu Mahadevan holds a patent for her invention titled "3′,5′-dimethoxybenzoyl-3'-amino-3′-deoxy adenosine-5′-triphosphates and pharmaceutical uses thereof." This patent includes compounds that exhibit P2X3 receptor or P2X2/3 receptor antagonist activity. These compounds are useful for treating diseases and disorders characterized by the activation of these receptors. The patent highlights the innovative nature of her work in creating effective pharmaceutical solutions.

Career Highlights

Throughout her career, Anu has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Danmir Therapeutics, LLC. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research.

Collaborations

Anu has collaborated with esteemed colleagues such as Amir Pelleg and Jie Li. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Anu Mahadevan is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. Her innovative patents and collaborations reflect her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…